| Year |
Citation |
Score |
| 2005 |
Huang Y, Guler L, Heidbrink J, Kenttämaa H. Reactions of charged phenyl radicals with aliphatic amino acids in the gas phase. Journal of the American Chemical Society. 127: 3973-8. PMID 15771534 DOI: 10.1021/Ja044676W |
0.874 |
|
| 2004 |
Heidbrink JL, Amegayibor FS, Kenttämaa HI. Gas-phase radical-radical recombination reactions of nitroxides with substituted phenyl radicals International Journal of Chemical Kinetics. 36: 216-229. DOI: 10.1002/Kin.10189 |
0.822 |
|
| 2003 |
Ramírez-Arizmendi LE, Heidbrink JL, Guler LP, Kenttämaa HI. Reactivity of substituted charged phenyl radicals toward components of nucleic acids. Journal of the American Chemical Society. 125: 2272-81. PMID 12590557 DOI: 10.1021/Ja020632G |
0.662 |
|
| 2002 |
Petzold CJ, Ramírez-Arizmendi LE, Heidbrink JL, Pérez J, Kenttämaa HI. Gas-phase reactions of charged phenyl radicals with neutral biomolecules evaporated by laser-induced acoustic desorption. Journal of the American Society For Mass Spectrometry. 13: 192-4. PMID 11838023 DOI: 10.1016/S1044-0305(01)00344-0 |
0.687 |
|
| 2001 |
Heidbrink JL, Ramírez-Arizmendi LE, Thoen KK, Guler L, Kenttämaa HI. Polar Effects Control Hydrogen-Abstraction Reactions of Charged, Substituted Phenyl Radicals The Journal of Physical Chemistry A. 105: 7875-7884. DOI: 10.1021/Jp0103676 |
0.71 |
|
| 2000 |
Heidbrink JL, Thoen KK, Kenttämaa HI. Polar Effects on Iodine Atom Abstraction by Charged Phenyl Radicals The Journal of Organic Chemistry. 65: 645-651. DOI: 10.1021/Jo981911I |
0.846 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1996 |
Meyer GW, Heidbrink JL, Franchina JG, Davis RM, Gardner S, Vasudevan V, Glass TE, McGrath JE. Phenylmaleimide endcapped arylene ether imide oligomers Polymer. 37: 5077-5088. DOI: 10.1016/0032-3861(96)00515-0 |
0.212 |
|
| 1996 |
Heidbrink JL, Li J, Pan W, Gooding JL, Aubuchon S, Foreman J, Lundgren C. Distinction of nontronite from palagonite by thermal analysis and evolved-gas analysis: Application to Mars surface exploration Thermochimica Acta. 284: 241-251. DOI: 10.1016/0040-6031(96)02920-6 |
0.191 |
|
| 1994 |
Shao D, Hutchinson EJ, Heidbrink J, Pan WP, Chou CL. Behavior of sulfur during coal pyrolysis Journal of Analytical and Applied Pyrolysis. 30: 91-100. DOI: 10.1016/0165-2370(94)00807-8 |
0.128 |
|
| 2009 |
Kim YJ, Feild B, Fitzhugh W, Heidbrink JL, Duff JW, Heil J, Ruben SM, He T. Reference map for liquid chromatography-mass spectrometry-based quantitative proteomics. Analytical Biochemistry. 393: 155-62. PMID 19538932 DOI: 10.1016/j.ab.2009.06.015 |
0.058 |
|
| 2009 |
Aggarwal S, He T, Fitzhugh W, Rosenthal K, Feild B, Heidbrink J, Mesmer D, Ruben SM, Moore PA. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer. Gynecologic Oncology. 115: 430-7. PMID 19800108 DOI: 10.1016/j.ygyno.2009.08.031 |
0.045 |
|
| 2006 |
Mesri M, Heidbrink J, McKinnon K, Brand E, He T, Lee C, Van Orden K, Birse C, Ruben S, Moore P. 55 POSTER Cell surface proteomic analysis of human renal tumor endothelium European Journal of Cancer Supplements. 4: 21. DOI: 10.1016/S1359-6349(06)70061-1 |
0.025 |
|
| 2015 |
Birse CE, Lagier RJ, FitzHugh W, Pass HI, Rom WN, Edell ES, Bungum AO, Maldonado F, Jett JR, Mesri M, Sult E, Joseloff E, Li A, Heidbrink J, Dhariwal G, et al. Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium. Clinical Proteomics. 12: 18. PMID 26279647 DOI: 10.1186/s12014-015-9090-9 |
0.022 |
|
| 2012 |
Lee CN, Heidbrink JL, McKinnon K, Bushman V, Olsen H, FitzHugh W, Li A, Van Orden K, He T, Ruben SM, Moore PA. RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival. Pancreas. 41: 84-94. PMID 21934552 DOI: 10.1097/MPA.0b013e3182236385 |
0.017 |
|
| 2004 |
Chromy BA, Perkins J, Heidbrink JL, Gonzales AD, Murphy GA, Fitch JP, McCutchen-Maloney SL. Proteomic characterization of host response to Yersinia pestis and near neighbors. Biochemical and Biophysical Research Communications. 320: 474-9. PMID 15219853 DOI: 10.1016/J.Bbrc.2004.05.199 |
0.017 |
|
| 2006 |
He T, Jin Kim Y, Heidbrink JL, Moore PA, Ruben SM. Drug target identification and quantitative proteomics. Expert Opinion On Drug Discovery. 1: 477-89. PMID 23495947 DOI: 10.1517/17460441.1.5.477 |
0.01 |
|
| 2013 |
Mesri M, Birse C, Heidbrink J, McKinnon K, Brand E, Bermingham CL, Feild B, Fitzhugh W, He T, Ruben S, Moore PA. Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues. Plos One. 8: e78885. PMID 24236063 DOI: 10.1371/journal.pone.0078885 |
0.01 |
|
| Hide low-probability matches. |